OCUL · Ocular Therapeutix, Inc
$10.04
-0.06 (-0.59%)
At close · Aug 14
Market Cap
$2.20B
Shares
219.62M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding OCUL
196 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Growth Company Fund | — | 9,716,358 | $87,544,386 | 0.09% | Long | 2026-05-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 6,550,102 | $55,479,364 | 0.00% | Long | 2026-03-31 | |
| iShares Russell 2000 ETF | — | 4,599,969 | $38,961,737 | 0.05% | Long | 2026-03-31 | |
| Fidelity Growth Company K6 Fund | — | 2,688,679 | $24,224,998 | 0.09% | Long | 2026-05-31 | |
| Fidelity Series Growth Company Fund | — | 2,611,078 | $23,525,813 | 0.10% | Long | 2026-05-31 | |
| Fidelity Small Cap Index Fund | — | 1,860,077 | $17,428,921 | 0.05% | Long | 2026-04-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 1,949,505 | $16,512,307 | 0.02% | Long | 2026-03-31 | |
| iShares Russell 2000 Growth ETF | — | 1,531,041 | $12,967,917 | 0.11% | Long | 2026-03-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 1,475,000 | $12,493,250 | 0.10% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 1,439,766 | $12,194,818 | 0.11% | Long | 2026-03-31 | |
| Select Pharmaceuticals Portfolio | — | 1,331,717 | $11,998,770 | 0.80% | Long | 2026-05-31 | |
| Invesco Pharmaceuticals ETF | — | 1,091,691 | $10,229,145 | 3.07% | Long | 2026-04-30 | |
| AB Small Cap Growth Portfolio | — | 1,029,122 | $9,642,873 | 0.33% | Long | 2026-04-30 | |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | — | 1,071,000 | $9,071,370 | 0.11% | Long | 2026-03-31 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 965,858 | $8,702,381 | 0.05% | Long | 2026-05-31 | |
| AB DISCOVERY GROWTH FUND, INC. | — | 885,803 | $8,299,974 | 0.31% | Long | 2026-04-30 | |
| Fidelity Extended Market Index Fund | — | 902,797 | $8,134,201 | 0.02% | Long | 2026-05-31 | |
| BlackRock Advantage Small Cap Core Fund | — | 843,005 | $7,595,475 | 0.14% | Long | 2026-05-29 | |
| Schwab U.S. Small-Cap ETF | — | 842,934 | $7,594,835 | 0.03% | Long | 2026-05-31 | |
| Select Biotechnology Portfolio | — | 784,000 | $7,063,840 | 0.13% | Long | 2026-05-31 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | — | 736,950 | $6,639,920 | 0.00% | Long | 2026-05-31 | |
| Fidelity Small Cap Growth Fund | — | 640,446 | $6,000,979 | 0.07% | Long | 2026-04-30 | |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF | — | 621,423 | $5,263,453 | 1.71% | Long | 2026-03-31 | |
| Dimensional U.S. Small Cap ETF | — | 528,156 | $4,948,822 | 0.04% | Long | 2026-04-30 | |
| Artisan International Small-Mid Fund | — | 559,675 | $4,740,447 | 0.18% | Long | 2026-03-31 | |
| Select Health Care Portfolio | — | 494,535 | $4,455,760 | 0.08% | Long | 2026-05-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 479,653 | $4,321,674 | 0.02% | Long | 2026-05-31 | |
| iShares U.S. Pharmaceuticals ETF | — | 486,759 | $4,122,849 | 0.41% | Long | 2026-03-31 | |
| Schwab Small-Cap Index Fund | — | 412,396 | $3,864,151 | 0.05% | Long | 2026-04-30 | |
| EQ/AB Small Cap Growth Portfolio | — | 410,791 | $3,479,400 | 0.18% | Long | 2026-03-31 | |
| abrdn Healthcare Investors | HQH | 376,318 | $3,187,413 | 0.28% | Long | 2026-03-31 | |
| Fidelity Small Cap Growth K6 Fund | — | 329,204 | $3,084,641 | 0.07% | Long | 2026-04-30 | |
| Fidelity Total Market Index Fund | — | 323,602 | $2,915,654 | 0.00% | Long | 2026-05-31 | |
| Allspring Small Company Growth Fund | — | 303,716 | $2,845,819 | 0.55% | Long | 2026-04-30 | |
| SmallCap Growth Fund I | — | 303,709 | $2,845,753 | 0.12% | Long | 2026-04-30 | |
| Fidelity Advisor Health Care Fund | — | 277,371 | $2,598,966 | 0.09% | Long | 2026-04-30 | |
| Master Small Cap Index Series | — | 306,197 | $2,593,489 | 0.05% | Long | 2026-03-31 | |
| Fidelity Series Total Market Index Fund | — | 265,018 | $2,387,812 | 0.00% | Long | 2026-05-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 258,781 | $2,331,617 | 0.04% | Long | 2026-05-29 | |
| Nuveen Small Cap Blend Index Fund | — | 225,988 | $2,117,508 | 0.05% | Long | 2026-04-30 | |
| U.S. MICRO CAP PORTFOLIO | — | 224,999 | $2,108,241 | 0.03% | Long | 2026-04-30 | |
| Optimum Small-Mid Cap Growth Fund | — | 234,547 | $1,986,613 | 0.26% | Long | 2026-03-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 231,968 | $1,964,769 | 0.00% | Long | 2026-03-31 | |
| Dimensional U.S. Core Equity 2 ETF | — | 184,477 | $1,728,549 | 0.00% | Long | 2026-04-30 | |
| EQ/2000 Managed Volatility Portfolio | — | 194,007 | $1,643,239 | 0.05% | Long | 2026-03-31 | |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND | — | 176,683 | $1,591,914 | 0.09% | Long | 2026-05-31 | |
| abrdn Life Sciences Investors | HQL | 182,062 | $1,542,065 | 0.27% | Long | 2026-03-31 | |
| iShares ESG Aware MSCI USA Small-Cap ETF | — | 162,900 | $1,467,729 | 0.06% | Long | 2026-05-31 | |
| Nuveen Equity Index Fund | — | 154,181 | $1,444,676 | 0.00% | Long | 2026-04-30 | |
| LVIP State Street Small-Cap Index Fund | — | 145,700 | $1,430,774 | 0.06% | Long | 2026-06-30 |
Showing 1–50 of 196 positions
Key facts
CIK
1393434
CUSIP
67576A100
13F (30d)
247 filings
242 filers
Visit website
Investor relations